Digest Network Come funziona
Network
/
Società
Ni
Non verificato

Niagen Bioscience, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaSaluteScienza

7 comunicati stampa

Guarda tutti i comunicati
15/10/2026
Salute
Scienza
Farmaceutica
Biotecnologia
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Fonte
Niagen Bioscience, Inc.
Emittente
Business Wire
1.00
0
21/09/2026
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Newly Published Preclinical Study Demonstrates CD38 as a Driver of Age-Related NAD+ Decline, Older Mothers Have Lower NAD+ Levels in Placental Tissue, and NAD+ Restoration with Nicotinamide Riboside (NR) Improves Pregnancy Outcomes
Fonte
Niagen Bioscience, Inc.
Emittente
Business Wire
1.00
0
12/08/2026
Eventi
Salute
Comunicazione
Scienza
Sanità
Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference
Fonte
Niagen Bioscience, Inc.
Emittente
Business Wire
1.00
0
04/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
Fonte
Niagen Bioscience, Inc.
Emittente
Business Wire
1.00
0
16/07/2026
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Industria
Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research
Fonte
Niagen Bioscience, Inc.
Emittente
Business Wire
1.00
0
09/02/2026
Eventi
Industria
Scienza
Igiene alimentare
Comunicazione
Biotecnologia
Sanità
Salute
Niagen Bioscience is the Premiere Sponsor of the Inaugural “NAD for Health: Opportunities & Challenges” Conference Hosted by the University of Copenhagen
Fonte
Niagen Bioscience, Inc.
Emittente
Business Wire
1.00
0
06/08/2025
Biotecnologia
Sanità
Farmaceutica
Salute
Web e Social Network
Telefonia e Varie
Mercato azionario
Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook
Fonte
Niagen Bioscience, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0